1. Pre- and Post-operative determinants of transplantation-free survival after Fontan. The Australia and New Zealand experience
- Author
-
Chin L. Poh, Rachael L. Cordina, Ajay J. Iyengar, Diana Zannino, Leeanne E. Grigg, Gavin R. Wheaton, Andrew Bullock, Julian Ayer, Nelson Alphonso, Thomas L. Gentles, David S. Celermajer, and Yves d'Udekem
- Subjects
Functional Single Ventricle ,Congenital Heart Disease ,Late death ,Transplantation ,Heart Failure ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background: This review identifies the predictors of late mortality and heart transplantation that remain relevant in the contemporary population of patients with a Fontan circulation, focusing on the potential impact of post-Fontan morbidities on the late outlook of these patients. Methods and Results: A total of 1561 patients who had survived the Fontan operation in Australia or New Zealand from 1975 to 2018 were included in this review. Over a median duration of 11.4 years, there was a total of 117 deaths (7%) and 32 heart transplantations (2%). Freedom from death and heart transplantation at 10, 20 and 35 years post Fontan surgery were 94% (95% CI 93–95%), 87% (95 %CI 85–90%) and 66% (95 %CI 57–78%) respectively. Being male, having an atriopulmonary Fontan, pre-Fontan atrioventricular valve intervention, or prolonged pleural effusions post Fontan were predictive of late death or heart transplantation. However, time-dependent variables such as the development of atrial arrhythmia, protein/losing enteropathy or late ventricular dysfunction were stronger predictors of the same outcome. Patients who developed a time-dependent risk factor had a freedom from death and heart transplantation rate of 54% (95 %CI 43–66) at 15 years and 44% (95 %CI 33–57) at 25 years post Fontan. However, 95% (95 %CI 91–99) of patients without any of the identified risk factors were free from death or heart transplantation rate at 25 years post Fontan. Conclusion: In conclusion, the occurrence of post-operative complications such as PLE, arrhythmia and ventricular dysfunction will likely precede the late demise of these patients.
- Published
- 2021
- Full Text
- View/download PDF